Morton C A, Scholefield R D, Whitehurst C, Birch J
Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK.
J Dermatolog Treat. 2005;16(4):219-23. doi: 10.1080/09546630500283664.
The effective management of acne remains a challenge; achieving an optimal response whilst minimizing adverse events is often difficult. The rise in antibiotic resistance threatens to reduce the future usefulness of the current mainstay of therapy. The need for alternative therapies remains important. Phototherapy has previously been shown to be effective in acne, with renewed interest as both endogenous and exogenous photodynamic therapies are demonstrated for this condition.
To determine the effect of narrowband blue light in the reduction of inflammatory and non-inflammatory lesions in patients with mild to moderate acne and to evaluate patient tolerance of the therapy.
We performed an open study utilizing a blue LED light source in 30 subjects with mild to moderate facial acne. Two weeks after screening, lesions were counted and recorded by lesion type. Over 4 weeks, patients received eight 10- or 20-minute light treatments, peak wavelength 409-419 nm at 40 mW/cm2. Assessments were taken at weeks 5, 8 and 12 and lesion counts were recorded. Repeated measures-ANOVA and Dunnett's tests, respectively, allowed assessment of the different scores over time and permitted comparison of mean counts.
An overall effect on inflammatory counts was observed at week 5, and a statistically significant decrease in inflamed counts was detected at the week 8 assessments, which continued to week 12. There was little effect on non-inflamed lesions. The treatment was well tolerated with adverse events experienced generally rated as being mild and usually self-limiting.
Eight 10- or 20-minute treatments over 4 weeks with a narrowband blue light was found to be effective in reducing the number of inflamed lesions in subjects with mild to moderate acne. The treatment had little effect on the number of comedones. The onset of the effect was observable at the first assessment, at week 5, and maximal between weeks 8 and 12. Blue light phototherapy using a narrowband LED light source appears to be a safe and effective additional therapy for mild to moderate acne.
痤疮的有效管理仍然是一项挑战;在将不良事件降至最低的同时实现最佳疗效往往很困难。抗生素耐药性的增加可能会降低当前主要治疗方法在未来的效用。对替代疗法的需求仍然很重要。先前已证明光疗对痤疮有效,随着内源性和外源性光动力疗法在这种疾病中的应用得到证实,人们对其重新产生了兴趣。
确定窄带蓝光对轻至中度痤疮患者炎性和非炎性皮损减少的效果,并评估患者对该疗法的耐受性。
我们对30名轻至中度面部痤疮患者进行了一项使用蓝色发光二极管光源的开放性研究。筛选两周后,按皮损类型对皮损进行计数和记录。在4周内,患者接受8次10或20分钟的光照治疗,峰值波长为409 - 419 nm,强度为40 mW/cm²。在第5、8和12周进行评估并记录皮损计数。分别采用重复测量方差分析和邓尼特检验来评估不同时间的分数,并比较平均计数。
在第5周观察到对炎性计数有总体影响,在第8周评估时检测到炎性计数有统计学意义的下降,并持续到第12周。对非炎性皮损几乎没有影响。该治疗耐受性良好,所经历的不良事件一般被评为轻度且通常为自限性。
发现在4周内进行8次每次10或20分钟的窄带蓝光治疗可有效减少轻至中度痤疮患者的炎性皮损数量。该治疗对粉刺数量影响不大。在第1次评估即第5周时可观察到疗效开始出现,在第8至12周之间达到最大。使用窄带发光二极管光源的蓝光光疗似乎是一种安全有效的轻至中度痤疮辅助治疗方法。